Brief: Tiziana Life Sciences Reports Resignation Of CEO
July 15 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES ANNOUNCES RESIGNATION OF CEO
* TIZIANA LIFE SCIENCES - BOARD ACCEPTED VOLUNTARY
RESIGNATION OF
KUNWAR SHAILUBHAI AS CEO, BOARD DIRECTOR, EFFECTIVE AS OF AUGUST
1, 2022
* TIZIANA LIFE SCIENCES LTD - HAS APPOINTED GABRIELE
CERRONE,
EXECUTIVE CHAIRMAN OF TIZIANA, AS INTERIM CHIEF EXECUTIVE
OFFICER
* TIZIANA LIFE SCIENCES LTD - WILL BEGIN A SEARCH FOR A
PERMANENT
CHIEF EXECUTIVE OFFICER AND CHIEF SCIENTIFIC OFFICER IMMEDIATELY
Source text for Eikon: ID:nGNXbMbGlG
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tiziana Life Sciences
See all newsTiziana's experimental MS treatment meets main goals in mid-stage study
Brief: Tiziana Life Sciences - Submits Request To FDA For Orphan Drug Designation For Intranasal Foralumab For Msa
Brief: Tiziana Announces Last Patient Completes Last Visit In Phase 2A Inform-MS Trial Of Intranasal Foralumab
Brief: Tiziana Announces Last Patient Successfully Dosed In Its Phase 2 Inform-MS Trial
Brief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis